CBP Sets June 15 Deadline for FDA Entries and Entry Summaries
As of June 15, ACE will be the only authorized system for filing electronic entries and entry summaries for certain Food and Drug Administration entries and entry summaries under certain entry types, said CBP in a Federal Register notice scheduled…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
for publication on Monday (here). On June 15, for entry types 01, 03, 06, 11, 23, 51 and 52, the Automated Commercial System “will no longer be a CBP-authorized [electronic system] for purposes of processing these electronic filings,” it said. “CBP will continue to monitor the FDA filing rates in ACE. Should there be a need to avoid a substantial adverse impact on trade, CBP will reassess the transition completion date for FDA filings,” said CBP. The Customs Commercial Operations Advisory Committee (COAC) recently joined industry calls for CBP to announce its ACE deadline for FDA entries, citing the trade industry’s need to know the date for development and training purposes.